好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Kallikrein-10 (KLK10) Haplotypes in GAD-positive Stiff-person Syndrome (SPS) Reveal Variants Linked to Biomarkers Regarding Disease Susceptibility, Risk, and Frequency
Autoimmune Neurology
S30 - Autoimmune Neurology: Clinical CNS Autoimmune and Inflammatory Disorders (4:30 PM-4:42 PM)
006
Characterize KLK10 haplotype structures in GAD-positive SPS and explore their association with genetic susceptibility or risk factors.
A recent whole-exome and Sanger sequencing study of 19 GAD-positive SPS patients and 20 immune disease controls (including two family members with diabetes and very high Anti-GAD-Ab titers but no SPS) revealed seven polymorphisms in the KLK10 gene shared by all SPS patients, suggesting that KLK10 is a genetic biomarker contributing to SPS immunopathogenesis by affecting neuro–immune cell signalling (Tsiortou et al., N2 doi:10.1212/NXI.0000000000200373).

KLK10 polymorphisms from the same 19 Anti-GAD-Ab SPS and 20 immune controls were analysed using LDpair, LDmatrix, LDhap, and 1000-Genomes Project (EUR). Variants were annotated with Ensembl and gnomAD, and their significance was explored using GWAS Catalog, FORGEdb/RegulomeDB, GTEx, and large proteogenomic studies.

Variant-phased analysis identified two dominant KLK10 haplotypes with strong linkage disequilibrium: the Variant-haplotype in 95% of SPS patients and the Ancestral-haplotype in 90% of controls. A splice-region polymorphism perfectly distinguished the two haplotypes and was associated with transcript isoforms having different 5′-Untranslated Regions (5'UTRs) and untranslated first exons, which affect mRNA stability and tissue-specific expression. The Variant-haplotype, but not the Ancestral-haplotype, was found to correlate with promoter/5′UTR sub-blocks containing SNPs linked to reduced mRNA expression and KLK10 protein levels (GTEx, proteogenomics), suggesting KLK10 haplotype-specific regulatory effects. Two non-SPS family members with diabetes and very high Anti-GAD-Ab titers were homozygous for the Ancestral-haplotype; in contrast, the family member with SPS had inherited the Variant-haplotype from her healthy mother. From 1000-Genomes project, the Ancestral-haplotype is rare (<2%) in African-ancestry populations; in contrast, the Variant-haplotype is relatively common, probably explaining the high frequency of SPS among African Americans.

KLK10 haplotypes are promising biomarkers regarding SPS risk, frequency and genetic susceptibility, prompting ongoing studies of differential KLK10 expression and disease-associated isoform transcripts.
Authors/Disclosures
Marinos C. Dalakas, MD, FAAN (Thomas Jefferson University)
PRESENTER
Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Konstantinos Barsakis Mr. Barsakis has nothing to disclose.
Popianna Tsiortou Popianna Tsiortou has nothing to disclose.